Drug Type Small molecule drug |
Synonyms K-2000 series, KAR-2581, OS-HDI-3 |
Target |
Action inhibitors |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Graft Rejection | Discovery | United Kingdom | - | |
| Multiple Sclerosis | Discovery | United Kingdom | - | |
| Neoplasms | Discovery | United Kingdom | - | |
| Psoriasis | Discovery | United Kingdom | - | |
| Rheumatoid Arthritis | Discovery | United Kingdom | - | |
| Systemic Lupus Erythematosus | Discovery | United Kingdom | - |





